Breaking News Instant updates and real-time market news.

UA

Under Armour

$15.67

-0.47 (-2.91%)

, UAA

Under Armour

$17.06

-0.315 (-1.81%)

10:45
09/19/17
09/19
10:45
09/19/17
10:45

Athletic gear oversupply worries fuel downgrades of Under Armour, Nike

Shares of Under Armour (UAA) and Nike (NKE) are slipping after the two athletic gear makers saw their ratings lowered amid concerns about their sector. Wells Fargo analyst Tom Nikic downgraded Under Armour to Underperform as he believes the athletic wear/footwear space "appears poised to take a breather for now," while his peer at Susquehanna cut Nike to Neutral on basketball product oversupply concerns. SELL UNDER ARMOUR: In a research note to investors, Wells Fargo's Nikic downgraded Under Armour to Underperform from Market Perform and lowered his price target on the shares to $13 from $17. The analyst noted that while the athletic apparel/footwear space was one of the strongest sub-sectors in his group coming out of the recession, he now sees several areas for concern that are not only likely weighing on the industry, but also have the potential to accelerate. With consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now," Nikic argued. Furthermore, the analyst pointed out that athletic trends have worsened, with sneaker retailers now underperforming non-athletic shoe stores for the first since the fourth quarter of 2011. Nikic believes the trend change away from performance has left Under Armour "offsides" from a fashion perspective and, unlike Nike, Under Armour still generates most of its revenue in North America, where the athletic space is seeing much more pressure. Additionally, Under Armour's stock valuation "still appears quite lofty," he contended. The analyst also lowered his estimates for Nike, Under Armour, lululemon (LULU) and Finish Line (FINL). NIKE TO THE SIDELINES: Meanwhile, Susquehanna analyst Sam Poser downgraded Nike to Neutral from Positive, stating that his checks indicate that the North American and European businesses are decelerating as some key categories, especially basketball, have underperformed, resulting in excess inventory that will pressure sales and margins. Nike appears to have misjudged the appetite for some key marquee basketball product, which has resulted in supply outpacing demand, he added. Poser told investors that he also believes Nike will provide a new five-year growth plan and push out its $50B revenue target beyond 2020. The analyst lowered his price target on the shares to $54 from $64, and pointed out that the problems facing Nike for the foreseeable future are evident by the guidance reductions from Foot Locker (FL), Dicks Sporting (DKS), Hibbett Sports (HIBB), and Finish Line. Jefferies analyst Randal Konik was also bearish on Nike this morning, lowering his price target on the shares to $49 from $60. According to his survey work, Nike is ceding market share to adidas (ADDYY) in both Europe and the U.S. at an accelerating pace, especially in running. The analyst's webscrape analysis shows Nike has 35 shoes in the top 60 sellers, versus 52 last year, while adidas has risen to 24 styles, versus just two last year. Further, Konik pointed out that Nike promotions are up year over year and are higher than adidas, adding that the former's share in basketball seems to have peaked. He reiterated a Hold rating on Nike's shares, and argued that the company's eroding market share is negative for both Foot Locker and Finish Line. PRICE ACTION: In morning trading, shares of Nike have dropped about 1% to $53, while Under Armour has slipped over 2.5% to under $17 per Class A share.

UA

Under Armour

$15.67

-0.47 (-2.91%)

UAA

Under Armour

$17.06

-0.315 (-1.81%)

NKE

Nike

$53.19

-0.31 (-0.58%)

LULU

lululemon

$59.76

-0.84 (-1.39%)

FINL

Finish Line

$9.88

-0.61 (-5.82%)

FL

Foot Locker

$35.43

-0.83 (-2.29%)

DKS

Dick's Sporting

$27.36

0.01 (0.04%)

HIBB

Hibbett Sports

$13.15

-0.7 (-5.05%)

ADDYY

adidas

$117.60

-0.6 (-0.51%)

  • 21

    Sep

  • 22

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

UA Under Armour
$15.67

-0.47 (-2.91%)

09/19/17
09/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Market Perform at Wells Fargo with Wells Fargo with analyst Tom Nikic saying with consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now." The analyst cut his price target for the shares to $13 from $17. 2. Kellogg (K) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Lavery saying cereal could be at risk from shrinking center store space. 3. Nike (NKE) downgraded to Neutral from Positive at Susquehanna saying that his checks indicate that the North American and European businesses are decelerating as some key categories, especially basketball, have underperformed, resulting in excess inventory that will pressure sales and margins. 4. Synchronoss (SNCR) downgraded to Underperform from Outperform at Raymond James with analyst Tavis McCourt citing the news that Siris Capital is no longer interested in an all-cash transaction for all the outstanding shares of the company and has withdrawn its $18 per share bid from June 22. Further, the analyst believes it increasingly unlikely that the current strategic review will result in an acquisition at a premium and expects share to come under pressure and stay in the range prior to the Siris indication of interest. 5. Sony (SNE) downgraded to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/17
WELS
09/19/17
DOWNGRADE
Target $13
WELS
Underperform
Under Armour downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Tom Nikic downgraded Under Armour (UAA) to Underperform and cut his price target for the shares to $13 from $17. With consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now," Nikic tells investors in a research note. The analyst believes the trend change away from performance has left Under Armour "offsides" from a fashion perspective. Further, he notes that unlike Nike (NKE), Under Armour still generates most of its revenue in North America, where the athletic space is seeing much more pressure. The stock's valuation "still appears quite lofty," Nikic argues. The analyst lowered his estimates for Nike, Under Armour, lululemon (LULU) and Finish Line (FINL), but downgraded only Under Armour.
09/13/17
BARD
09/13/17
NO CHANGE
Target $25
BARD
Outperform
Under Armour near-term estimates have been appropriately set, says Baird
Baird analyst Jonathan Kemp said he remains comfortable that near-term estimates for Under Armour have been appropriately set, although skepticism about Q4 will likely remain in the short-term. He remains optimistic that structural changes to the business model can yield improving results into 2018 and beyond. Kemp reiterated his Outperform rating based on a 6-12 month view and maintained his $25 price target on Under Armour shares.
09/12/17
09/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with an Outperform at Macquarie. 2. Bunge (BG) initiated with a Neutral at Baird. 3. Rite Aid (RAD) initiated with a Hold at Loop Capital. 4. Nike (NKE) was initiated with an Outperform at Bernstein, while Under Armour (UA) was initiated with an Underperform. 5. Houlihan Lokey (HLI) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
UAA Under Armour
$17.06

-0.315 (-1.81%)

09/12/17
BERN
09/12/17
INITIATION
Target $14
BERN
Underperform
Under Armour initiated with an Underperform at Bernstein
Bernstein analyst Jamie Merriman started Under Armour with an Underperform rating and $14 price target as he believes it is now in "growth purgatory." While growth will remain in the high single digits-low double digits, the analyst does not believe recovering back to over 20% will occur on a sustainable basis.
NKE Nike
$53.19

-0.31 (-0.58%)

09/19/17
BOFA
09/19/17
NO CHANGE
Target $42
BOFA
Underperform
Nike risk/reward remains unfavorable, says BofA/Merrill
BofA/Merrill analyst Robert Ohmes believes Nike to report Q1 earnings next Tuesday above consensus of 48c given conservative guidance but expects a muted outlook due to weakening data points. Ohmes said retail partner same-store sales have deteriorated from last quarter, SportScan data continues to deteriorate, the promotional environment remains elevated, the company continues to lose share to adidas, the e-commerce channel has become a "dumping ground" for clearance and discounting, and VaporMax sales are not yet meaningful. The analyst maintains his Underperform rating and $42 price target on Nike and said risk/reward remains unfavorable.
09/19/17
SUSQ
09/19/17
DOWNGRADE
Target $54
SUSQ
Nike downgraded to Neutral on basketball product oversupply at Susquehanna
As previously reported, Susquehanna analyst Sam Poser downgraded Nike to Neutral from Positive, stating that his checks indicate that the North American and European businesses are decelerating as some key categories, especially basketball, have underperformed, resulting in excess inventory that will pressure sales and margins. Poser also believes Nike will provide a new five-year growth plan and push out its $50B revenue target beyond 2020, he tells investors. The analyst cut his price target on Nike shares to $54 from $64. The Dow member's stock closed at $53.50 yesterday and is sliding another 1.5% in pre-market trading this morning.
09/19/17
SUSQ
09/19/17
DOWNGRADE
SUSQ
Neutral
Nike downgraded to Neutral from Positive at Susquehanna
LULU lululemon
$59.76

-0.84 (-1.39%)

09/05/17
SUSQ
09/05/17
UPGRADE
Target $71
SUSQ
Positive
lululemon upgraded to Positive at Susquehanna
As previously reported, Susquehanna analyst Sam Poser upgraded lululemon to Positive from Neutral. The analyst cited improved product mix, momentum carrying into Q3 and inventory flow to stores that is finally supporting consumer engagement. He believes the shares are at a positive inflection point, which he believes can be sustained. Poser raised his price target to $71 from $64 on lululemon.
09/05/17
09/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone." 2. Patterson-UTI (PTEN) upgraded to Overweight from Neutral at JPMorgan with analyst Sean Meakim saying the 26% selloff since July 19 has created a buying opportunity. 3. lululemon (LULU) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser citing improved product mix, momentum carrying into the third quarter and inventory flow to stores that is finally supporting consumer engagement. 4. U.S. Steel (X) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners saying the U.S. premium to Chinese prices has fallen to just about $75/ton, half the leves he considers "normal" and expects HRC can "surge toward $700/ton by year end. 5. Prologis (PLD) upgraded to Buy from Hold at SunTrust with analyst Ki Bin Kim citing valuation and several positive catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
BERN
09/12/17
INITIATION
Target $66
BERN
Market Perform
lululemon initiated with a Market Perform at Bernstein
Bernstein analyst Jamie Merriman started lululemon with a Market Perform rating and $66 price target.
FINL Finish Line
$9.88

-0.61 (-5.82%)

09/18/17
WELS
09/18/17
NO CHANGE
WELS
Retail seems to be stabilizing, says Wells Fargo
Wells Fargo analyst Ike Boruchow says that while it still seems too early to call for a robust recovery in retail fundamentals, the industry does seem to be stabilizing, with Q2 sales and EPS trends generally better than Q1 across the board. Further, store traffic has improved each month since February and management teams have taken a generally upbeat tone regarding back-to-school in recent public commentary, he adds. So, with solid traffic and favorable weather during the key back-to-school selling season, the analyst believes inventories could find themselves in good shape heading into the holidays and momentum appears to be on retail's side. Boruchow points out that according to his index, PVH Corp. (PVH) continues to be the ''most loved'' retailer in his universe, followed by TJX (TJX), Canada Goose (GOOS), and Steven Madden (SHOO), while Foot Locker (FL), Fossil (FOSL), and Finish Line (FINL) are the ''least loved'' names this month.
09/18/17
09/18/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Finish Line (FINL) downgraded to Underweight from Neutral at Piper Jaffray with analyst Erinn Murphy saying she sees further downside risk to estimates. 2. United Continental (UAL) downgraded to Neutral from Buy at Buckingham with the firm's analyst cutting his 2018 pre-tax earnings forecast by 20% and expects the multiple to contract further as consensus estimates are reset lower. 3. Brooks Automation (BRKS) downgraded to Hold from Buy at Needham with analyst Y. Edwin Mok citing valuation. 4. Wipro (WIT) downgraded to Sell from Neutral at Goldman Sachs with the firm saying earnings growth stays anemic while valuation is rich. 5. Taubman Centers (TCO) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Richard Hill stating that while Taubman owns the highest quality portfolio of malls, its second quarter results showed its smaller portfolio may give it less negotiating leverage with retailers than peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/17
JEFF
09/19/17
NO CHANGE
JEFF
Jefferies cuts Nike target, says share loss to adidas accelerating
Survey work shows Nike (NKE) is ceding market share to adidas (ADDYY) in both Europe and the U.S. at an accelerating pace, especially in running, Jefferies analyst Randal Konik tells investors in a research note. The analyst's webscrape analysis shows Nike has 35 shoes in the top 60 sellers versus 52 last year, while adidas has risen to 24 styles, versus just 2 last year. Konik expects downward estimate revisions and multiple compression for Nike. He lowered his estimates for the company and cut his price target for the shares to $49 from $60. The shoemaker closed yesterday down 37c to $53.50. The analyst reiterates a Hold rating on the name. Konik also views Nike's eroding market share as negative for both Foot Locker (FL) and Finish Line (FINL).
FL Foot Locker
$35.43

-0.83 (-2.29%)

08/29/17
MSCO
08/29/17
NO CHANGE
Target $50
MSCO
Overweight
Foot Locker problems fixable, mostly fashion-related, says Morgan Stanley
Morgan Stanley analyst Jay Sole made his case for keeping an Overweight rating on Foot Locker (FL) in a new note to investors, arguing that the problems that caused the company's "very disappointing" Q2 results were not structural, but "mostly fashion-related" and fixable. He still sees the stock's risk/reward balance skewed to the upside, based on his belief that Foot Locker can defend itself versus Amazon (AMZN), Nike's (NKE) new product pipeline should eventually improve and brands' quicker speed to market "could be a game-changer." However, Sole has lowered his price target on Foot Locker shares to $50 from $65.
08/29/17
SBSH
08/29/17
DOWNGRADE
Target $5
SBSH
Sell
Finish Line downgraded to Sell from Neutral at Citi
Citi analyst Kate McShane downgraded Finish Line (FINL) to Sell and cut her price target for the shares to $5 from $14 after the company preannounced a Q2 miss and cut its outlook for the year. The shares in premarket trading are down 26%, or $2.71, to $7.71. The marketplace for athletic footwear became more promotional as Q2 progressed but Finish Line's earnings reduction appears worse than the market expected, McShane tells investors in a research note. She believes the competitive environment among athletic retailers "has only become more difficult" and that Finish Line suffers from being a smaller mall- based chain relative to Dick's Sporting Goods (DKS) and Foot Locker (FL). FBR Capital this morning also downgraded Finish Line.
DKS Dick's Sporting
$27.36

0.01 (0.04%)

08/24/17
COWN
08/24/17
DOWNGRADE
Target $28
COWN
Market Perform
Dick's Sporting downgraded to Market Perform at Cowen
As previously reported, Cowen analyst John Kernan downgraded Dick's Sporting to Market Perform from Outperform citing his overestimation for the company to achieve guidance and maintain profitability in the face of structural and cyclical headwinds. He also noted the competition from other apparel companies, merchandising margin pressure, and shipping cost pressure. Kernan lowered his price target to $28 from $31 on Dick's Sporting shares.
08/24/17
COWN
08/24/17
DOWNGRADE
COWN
Market Perform
Dick's Sporting downgraded to Market Perform from Outperform at Cowen
08/24/17
08/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Underperform from Neutral at Credit Suisse by analyst Vamil Divan, saying that while Teva has dramatically reduced 2017 guidance, the core challenges they are facing should not fade anytime soon. The analyst pointed out that pricing pressure and increased competition in the U.S. generics business will remain, the appointment of a full-time CEO is still pending and the threat of generic competition to Copaxone 40mg still looms. 2. Lowe's (LOW) downgraded to Market Perform from Outperform at BMO Capital by analyst Wayne Hood based on the company's results and guidance which he said were "disappointing." The analyst expects the company's profitability to remain "challenged" going forward. 3. Dick's Sporting (DKS) downgraded to Market Perform from Outperform at Cowen, saying it had overestimated the company's ability to achieve its prior guidance and maintain its profitability. Cowen pointed to a number of headwinds for Dick's, including increasing digital competition and the negative side of industry cyclical trends. 4. J.M. Smucker (SJM) downgraded to Neutral from Overweight at JPMorgan. 5. LaSalle Hotel (LHO) downgraded to Neutral from Outperform at Boenning & Scattergood by analyst Floris van Dijkum citing recent share outperformance and potential declining comparable EBITDA that could pressure future NAV. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HIBB Hibbett Sports
$13.15

-0.7 (-5.05%)

07/25/17
ADAM
07/25/17
NO CHANGE
Target $14
ADAM
Hold
Hibbett Sports price target lowered to $14 from $22 at Canaccord
Canccord analyst Camilo Lyon lowered his price target on Hibbett Sports to $14 from $22 following the company's pre-announcement of "stunningly poor" results. The analyst noted the company expects Q2 comps to be down 10% along with significant gross margin pressure. The weakness was mainly due to a footwear miss led by decelerating in basketball and running, said Lyon, who maintained his Hold rating on Hibbett shares.
07/25/17
FBCO
07/25/17
NO CHANGE
Target $14
FBCO
Underperform
Hibbett Sports price target lowered to $14 from $24 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Hibbett Sports to $14 from $24 after the company preannounced weaker Q2 results, dragged down by comps, related expense deleverage and much weaker gross margins. The analyst adds that results reflect weak demand, growing online competition along with elevated investment requirements as the company launches its first transactional website. He reiterates an Underperform rating on the shares.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $52
FBCO
Neutral
Foot Locker price target lowered to $52 from $66 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Foot Locker (FL) to $52 from $66 given increasing industry headwinds and following disappointing commentary by peers Finish Line (FINL) and Hibbett Sports (HIBB). The analyst believes the best-in-class execution by Foot Locker may no longer be enough. He reiterates a Neutral rating on Foot Locker's shares.
08/18/17
BARD
08/18/17
NO CHANGE
Target $10
BARD
Neutral
Hibbett Sports price target lowered to $10 from $15 at Baird
Baird analyst Peter Benedict lowered his price target for Hibbett Sports to $10 after the company's Q2 comps missed expectations. While an FY17 earnings guidance cut was expected, the magnitude was more severe on continued top-line weakness and even more pronounced margin pressure, Benedict tells investors in a post-earnings research note. He maintains a Neutral rating on Hibbett.
ADDYY adidas
$117.60

-0.6 (-0.51%)

09/18/17
ADAM
09/18/17
NO CHANGE
Target $51
ADAM
Hold
Nike showing internal 'panic' and investors may lose patience, says Canaccord
Canaccord analyst Camilo Lyon said his industry contacts indicate that a resurging Adidas (ADDYY) has taken meaningful share from Nike, "to the point of causing panic internally. He believes Nike investors, who have exhibited an "extraordinary amount of patience," could perhaps see their patience wane if the company does not show progress with its "stale innovation pipeline." Nike's Q4 had red flags that clearly pointed to a significant sell-in of product, leaving "little room" for a "quality" Q1 sales beat, said Lyon, who predicts the company will post an "expense-driven beat on easy comparisons" with its report on September 26 but believes second half expectations remain far too optimistic. He keeps a Hold rating and $51 price target on Nike shares.
08/21/17
08/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Hold from Buy at Jefferies, with analyst Randal Konik saying valuation is expensive and the competitive landscape could make share gains and margin expansion difficult. Konik added Adidas' (ADDYY) success in reviving its brand appeal in North America has had a clear impact on Nike shares. 2. Foot Locker (FL) downgraded to Neutral from Buy at UBS and Finish Line (FINL) cut to Sell from Neutral by analyst Michael Binetti, who said Foot Locker's results were worse than the analyst expected and make it tougher to support a thesis that athletic retail will be able to sidestep the structural challenges of the broader sector. Binetti downgraded Finish Line based on the structural risks exposed by Foot Locker exposed in its Q2 report. 3. Barclays analyst Lydia Rainforth downgraded Total (TOT) and Repsol (REPYY) to Equal Weight from Overweight and Statoil (STO) and Eni SpA (E) to Underweight from Equal Weight citing relative valuation. 4. Canadian Solar (CSIQ) downgraded to Underweight from Equal Weight at Barclays, with analyst Jon Windham saying it faces risks from the possible delay of project sales and pricing, soft investor demand for a J-REIT listing in the second half, and risks from the September 22 injury vote in the US ITC 201 trade case. 5. Infosys (INFY) downgraded to Neutral from Overweight at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/18/17
PIPR
08/18/17
NO CHANGE
Target $35
PIPR
Neutral
Foot Locker price target lowered to $35 from $60 at Piper Jaffray
Piper Jaffray analyst Erinn Murphy lowered her price target for Foot Locker (FL) to $35 and reduced her estimates "materially" following the company's Q2 miss and guide down. Management referred to the rapidly changing landscape as some of the most significant shifts seen in history, Murphy points out in a research note. She sees the shift to more digital platforms as well as the brand leadership rotation from Nike (NKE) to adidas (ADDYY) as weighing on Foot Locker's traffic and margins. The analyst keeps a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

STLD

Steel Dynamics

$37.78

1.34 (3.68%)

21:35
10/19/17
10/19
21:35
10/19/17
21:35
Upgrade
Steel Dynamics rating change at KeyBanc »

Steel Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RXDX

Ignyta

$16.65

0.4 (2.46%)

20:30
10/19/17
10/19
20:30
10/19/17
20:30
Syndicate
Ignyta 10M share Secondary priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 20

    Oct

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

, GE

General Electric

$23.58

0.46 (1.99%)

20:25
10/19/17
10/19
20:25
10/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$91.59

-0.4904 (-0.53%)

GE

General Electric

$23.58

0.46 (1.99%)

HON

Honeywell

$143.62

0.18 (0.13%)

SLB

Schlumberger

$64.50

-1.41 (-2.14%)

STI

SunTrust

$59.11

-0.18 (-0.30%)

SYF

Synchrony

$31.71

0.2 (0.63%)

CFG

Citizens Financial

$37.43

0.25 (0.67%)

KSU

Kansas City Southern

$103.78

0.97 (0.94%)

GNTX

Gentex

$20.66

0.2 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 02

    Nov

WILC

G. Willi-Food

$5.85

-0.14 (-2.34%)

18:35
10/19/17
10/19
18:35
10/19/17
18:35
Hot Stocks
G. Willi-Food receives notice from Arla Food ending distribution agreement »

G. Willi-Food's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$71.26

-0.46 (-0.64%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Macquarie Infrastructure CEO to become CEO of Macquarie Atlas Roads in 2018 »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

BIDU

Baidu

$264.52

-4.45 (-1.65%)

18:30
10/19/17
10/19
18:30
10/19/17
18:30
Hot Stocks
Baidu collaborating with China's BAIC Group and King Long for autonomous driving »

Baidu signed strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

IBKC

Iberiabank

$80.15

0.05 (0.06%)

18:27
10/19/17
10/19
18:27
10/19/17
18:27
Hot Stocks
IBERIABANK to acquire Gibraltar Private Bank & Trust »

IBERIABANK Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

VBTX

Veritex

$27.04

-0.02 (-0.07%)

18:20
10/19/17
10/19
18:20
10/19/17
18:20
Hot Stocks
Veritex receives regulatory approval for Liberty Bancshares merger »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BHP

BHP Billiton

$41.56

0.06 (0.14%)

18:03
10/19/17
10/19
18:03
10/19/17
18:03
Hot Stocks
BHP Billiton CEO sees challenges around geopolitical uncertainty remaining »

In annual shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRRX

Durect

$1.97

0.03 (1.55%)

17:59
10/19/17
10/19
17:59
10/19/17
17:59
Hot Stocks
Durect: Phase 3 clinical trial for POSIMIR did not meet primary endpoint »

Durect reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.90

-0.1 (-5.00%)

17:49
10/19/17
10/19
17:49
10/19/17
17:49
Hot Stocks
Titan Pharmaceuticals presents non-clinical data from liothyronine implant »

Titan Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$82.20

1.37 (1.69%)

17:46
10/19/17
10/19
17:46
10/19/17
17:46
Earnings
MSA Safety reports Q3 EPS 92c, consensus 80c »

Reports Q3 revenue $296M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

SKX

Skechers

$24.03

-1.06 (-4.22%)

, CAI

CAI International

$31.38

-0.05 (-0.16%)

17:41
10/19/17
10/19
17:41
10/19/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SKX

Skechers

$24.03

-1.06 (-4.22%)

CAI

CAI International

$31.38

-0.05 (-0.16%)

PYPL

PayPal

$67.25

-0.01 (-0.01%)

MXIM

Maxim Integrated

$50.09

0.24 (0.48%)

IMDZ

Immune Design

$5.50

-1.05 (-16.03%)

NCR

NCR Corp.

$37.05

-0.26 (-0.70%)

TACO

Del Taco

$15.39

-0.01 (-0.06%)

ATHN

athenahealth

$116.41

-4.37 (-3.62%)

ISRG

Intuitive Surgical

$357.46

3.09 (0.87%)

ETFC

E-Trade

$43.69

-0.23 (-0.52%)

CELG

Celgene

$135.96

-1.21 (-0.88%)

PBMD

Prima BioMed

$2.36

-0.02 (-0.84%)

AAXN

Axon

$24.62

-0.37 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 21

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 29

    Nov

DGX

Quest Diagnostics

$93.23

1.18 (1.28%)

17:37
10/19/17
10/19
17:37
10/19/17
17:37
Hot Stocks
Quest Diagnostics acquires Cleveland HeartLab, terms not disclosed »

Advantage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

AAXN

Axon

$24.62

-0.37 (-1.48%)

17:34
10/19/17
10/19
17:34
10/19/17
17:34
Hot Stocks
Axon says now aware of comment letter over SEC's review of 10-K, 10-Q »

Axon Enterprise said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on BioPharmX »

BioPharmX files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.74

0.0248 (3.47%)

17:29
10/19/17
10/19
17:29
10/19/17
17:29
Syndicate
Breaking Syndicate news story on MabVax Therapeutics »

MabVax Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$80.15

0.05 (0.06%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Earnings
Iberiabank reports Q3 non-GAAP EPS $1.00, consensus $1.16 »

Reports Q3 core revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 15

    Nov

  • 28

    Nov

DRRX

Durect

$1.97

0.03 (1.55%)

17:28
10/19/17
10/19
17:28
10/19/17
17:28
Hot Stocks
Breaking Hot Stocks news story on Durect »

Durect trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCP

Quality Care Properties

$16.26

0.07 (0.43%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Quality Care Properties provides update on HCR ManorCare »

Quality Care Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$11.48

0.02 (0.17%)

, CHH

Choice Hotels

$68.45

0.25 (0.37%)

17:26
10/19/17
10/19
17:26
10/19/17
17:26
Hot Stocks
Frontier Communications named a Qualified Vendor with Choice Hotels Internationa »

Frontier Communications…

FTR

Frontier Communications

$11.48

0.02 (0.17%)

CHH

Choice Hotels

$68.45

0.25 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 08

    Nov

DRIO

DarioHealth

$1.98

-0.2 (-9.17%)

17:16
10/19/17
10/19
17:16
10/19/17
17:16
Syndicate
Breaking Syndicate news story on DarioHealth  »

DarioHealth files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBI

Customers Bancorp

$33.16

0.46 (1.41%)

17:11
10/19/17
10/19
17:11
10/19/17
17:11
Hot Stocks
Customers Bancorp to spin off BankMobile business »

Customers Bancorp plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 15

    Nov

MVC

MVC Capital

$10.40

0.08 (0.78%)

17:07
10/19/17
10/19
17:07
10/19/17
17:07
Hot Stocks
MVC Capital: Glass Lewis, Egan-Jones against proposal to cease new investments »

MVC Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CELG

Celgene

$135.96

-1.21 (-0.88%)

17:05
10/19/17
10/19
17:05
10/19/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Celgene »

Celgene down 6.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.